Vaccine Trial Centre: Pneumococcal Vaccine Project Timeline

2019
A Phase 3, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114 in healthy infants, children, and adolescents (PNEU-PLAN)
2024
Pneumovaccine vaccine in underlying disease children